Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease

Helicobacter pylori infection is associated with worse severity of Parkinson's disease

(2015) Ai Huey Tan et al.   PARKINSONISM & RELATED DISORDERS

Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes

(2014) Junko Sato et al.   DIABETES CARE

Gut microbiota are related to Parkinson's disease and clinical phenotype

(2014) Filip Scheperjans et al.   MOVEMENT DISORDERS

Small intestinal bacterial overgrowth in Parkinson's disease

(2014) Ai Huey Tan et al.   PARKINSONISM & RELATED DISORDERS

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

(2013) Jeffrey H. Kordower et al.   BRAIN

Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer

(2013) Seiji Ohigashi et al.   DIGESTIVE DISEASES AND SCIENCES

The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health

(2013) P.-H. Ding et al.   JOURNAL OF PERIODONTAL RESEARCH

The role of small intestinal bacterial overgrowth in Parkinson's disease

(2013) Alfonso Fasano et al.   MOVEMENT DISORDERS

Pilot study of H2therapy in Parkinson's disease: A randomized double-blind placebo-controlled trial

(2013) Asako Yoritaka et al.   MOVEMENT DISORDERS

Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease

(2013) Leo P. Kelly et al.   MOVEMENT DISORDERS

Diet rapidly and reproducibly alters the human gut microbiome

(2013) Lawrence A. David et al.   NATURE

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

(2013) V. K. Ridaura et al.   SCIENCE

Colonic inflammation in Parkinson's disease

(2012) David Devos et al.   NEUROBIOLOGY OF DISEASE

Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease

(2011) Maurizio Gabrielli et al.   MOVEMENT DISORDERS

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease

(2011) Kathleen M. Shannon et al.   MOVEMENT DISORDERS

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

(2011) Christopher B. Forsyth et al.   PLoS One

Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment

(2010) Yoshinori Fujiwara et al.   Geriatrics & Gerontology International

Bacterial rRNA-Targeted Reverse Transcription-PCR Used To Identify Pathogens Responsible for Fever with Neutropenia

(2010) S. Sakaguchi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Establishment of an Analytical System for the Human Fecal Microbiota, Based on Reverse Transcription-Quantitative PCR Targeting of Multicopy rRNA Molecules

(2009) K. Matsuda et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis

(2009) Mikihito Kajiya et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers

(2009) Raymond C.S. Seet et al.   FREE RADICAL BIOLOGY AND MEDICINE

Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease

(2009) Yuan Fu et al.   NEUROSCIENCE LETTERS

A timeline for Parkinson's disease

(2009) Christopher H. Hawkes et al.   PARKINSONISM & RELATED DISORDERS

Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease

(2009) Kyota Fujita et al.   PLoS One

The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery

(2008) Garima Dutta et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY